Wall Street is rebounding today thanks to continuing crude oil price declines, although volumes remain somewhat muted ahead of Nvidia's earnings, PCE inflation data, and the central banking symposium in Jackson Hole.
The return of risk appetite is confirmed by gains in the Nasdaq (US100: +0.3%) and subdued performance in the DJIA (US30: +0.05%). Optimism also extends to the S&P 500 (US500: +0.1%) and the Russell 2000 (US2000: +0.1%).
A notable trend today is a collective rebound among AI-related companies. The recent rise in US bond yields, concerns over AI company debt levels, and ongoing anticipation of Nvidia's earnings report had been exerting pressure on sector stocks. The rebound is led by memory producers (Nvidia +1.7%, Micron +1.7%, Sandisk +1.7%), chipmakers (Intel +1.6%, AMD +3.75%), and data center energy providers (Fluence +2.9%).
Optimism is also evident across the broader tech sector (Communication Services, e.g., Uber +0.7%, Meta +0.8%, Netflix +1.2%), while defensive sectors such as energy and consumer goods are largely posting losses.
S&P 500 stock volatility. Semiconductors, hardware, software, and communication services dominate. Source: XTB Research
Technical Analysis: US100 / Nasdaq fut. (D1)
Nasdaq 100 futures (US100) are experiencing a corrective pullback on the daily timeframe, testing a key demand zone between 29,140 and 29,300 points. This horizontal support level is reinforced by the 38.2% Fibonacci retracement level (29,141.84 pts). The index has fallen below its short-term moving averages—the 10-day EMA (29,447.31) and 30-day EMA (29,399.12)—signaling weakened bullish momentum. The 14-day RSI, sliding toward a neutral-to-bearish 47.6 points, does not yet show oversold conditions, leaving room for a deeper correction. A sustained breakdown below 29,141 points would open the path toward the 50% Fibonacci level (28,772.21 pts) and the 100-day EMA (28,664.11 pts).
Source: xStation5
Company News:
-
Kura Oncology (KURA.US): Shares are up 8.8% after CEO Troy Edward Wilson disclosed in an SEC filing the open-market purchase of 100,000 shares worth $1.24 million. The transaction bolstered positive sentiment surrounding the biotech company, whose stock has gained 19% over the past month, signaling strong management confidence in its continued growth.
-
Alibaba (BABA.US): Company founder Jack Ma purchased over HKD 600 million worth of shares, signaling massive confidence in the firm's AI ambitions. Chairman Joe Tsai and CEO Eddie Wu also joined in, buying shares worth a combined HKD 202 million. The purchases followed an HKD 80 billion share issuance to fund AI development. ADRs are up around 0.9%.
Crude Oil Dips Below 90 USD 🛢️ 📉
Market Wrap: Cautious rebound in Europe after the drop in oil prices
Nikkei 225 reverses morning losses
Chart of the Day: EURUSD Under Pressure from the Dollar. Bessent, PCE and Jackson Hole to Determine the Next Direction
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
